Business Description
ArcticZymes Technologies ASA
ISIN : NO0010014632
Description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.19 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.4 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 27.76 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.1 | |||||
| 3-Year EBITDA Growth Rate | -16.8 | |||||
| 3-Year EPS without NRI Growth Rate | -38.3 | |||||
| 3-Year FCF Growth Rate | -58.1 | |||||
| 3-Year Book Growth Rate | 14.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.38 | |||||
| 9-Day RSI | 28.56 | |||||
| 14-Day RSI | 32.59 | |||||
| 6-1 Month Momentum % | 3.43 | |||||
| 12-1 Month Momentum % | -22.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.96 | |||||
| Quick Ratio | 12.36 | |||||
| Cash Ratio | 8.27 | |||||
| Days Inventory | 714.12 | |||||
| Days Sales Outstanding | 47.18 | |||||
| Days Payable | 274.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | 0.14 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 95.02 | |||||
| Operating Margin % | 13.24 | |||||
| Net Margin % | 16.33 | |||||
| FCF Margin % | 2.63 | |||||
| ROE % | 6.53 | |||||
| ROA % | 5.93 | |||||
| ROIC % | 11.56 | |||||
| ROC (Joel Greenblatt) % | 36.31 | |||||
| ROCE % | 8.23 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 68.03 | |||||
| Forward PE Ratio | 66.23 | |||||
| PE Ratio without NRI | 68.03 | |||||
| Shiller PE Ratio | 234.74 | |||||
| Price-to-Owner-Earnings | 453.51 | |||||
| PS Ratio | 11.01 | |||||
| PB Ratio | 4.25 | |||||
| Price-to-Tangible-Book | 4.64 | |||||
| Price-to-Free-Cash-Flow | 391.67 | |||||
| Price-to-Operating-Cash-Flow | 53.85 | |||||
| EV-to-EBIT | 45.48 | |||||
| EV-to-Forward-EBIT | 49.96 | |||||
| EV-to-EBITDA | 36.31 | |||||
| EV-to-Forward-EBITDA | 39.62 | |||||
| EV-to-Revenue | 9.66 | |||||
| EV-to-Forward-Revenue | 9.05 | |||||
| EV-to-FCF | 336.46 | |||||
| Price-to-Projected-FCF | 3.07 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Graham-Number | 3.9 | |||||
| Price-to-Net-Current-Asset-Value | 5.26 | |||||
| Price-to-Net-Cash | 8.85 | |||||
| Earnings Yield (Greenblatt) % | 2.2 | |||||
| FCF Yield % | 0.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ArcticZymes Technologies ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 10.367 | ||
| EPS (TTM) (€) | 0.032 | ||
| Beta | 0.72 | ||
| Volatility % | 53.93 | ||
| 14-Day RSI | 32.59 | ||
| 14-Day ATR (€) | 0.053568 | ||
| 20-Day SMA (€) | 2.2735 | ||
| 12-1 Month Momentum % | -22.76 | ||
| 52-Week Range (€) | 2.115 - 3.86 | ||
| Shares Outstanding (Mil) | 50.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ArcticZymes Technologies ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ArcticZymes Technologies ASA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ArcticZymes Technologies ASA Frequently Asked Questions
What is ArcticZymes Technologies ASA(FRA:B4V)'s stock price today?
The current price of FRA:B4V is €2.12. The 52 week high of FRA:B4V is €3.86 and 52 week low is €2.12.
When is next earnings date of ArcticZymes Technologies ASA(FRA:B4V)?
The next earnings date of ArcticZymes Technologies ASA(FRA:B4V) is 2024-05-08.
Does ArcticZymes Technologies ASA(FRA:B4V) pay dividends? If so, how much?
ArcticZymes Technologies ASA(FRA:B4V) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers